FMP
Roivant Sciences Ltd.
ROIV
NASDAQ
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.
12 USD
0 (0%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.
CIK
0001635088
ISIN
BMG762791017
CUSIP
G76279101
Address
11-12 St. James's Square
Phone
44 2074 003 347
Country
GB
Employee
908
IPO Date
Dec 8, 2020
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
ROIV Financial Summary
CIK
0001635088
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
G76279101
ISIN
BMG762791017
Country
GB
Price
12
Beta
1.24
Volume Avg.
4.73M
Market Cap
8.74B
Shares
-
52-Week
9.69-13.055
DCF
-1.03
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
2.17
P/B
-
Website
https://roivant.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest ROIV News
It looks like there's no news available.
